GLP-1 medications and PCOS: separating real data from TikTok hope

What did @mariahhopkins_ actually say?

She said GLP-1 medications "might help if you're struggling to get pregnant" and noted that IVF doctors are reportedly prescribing GLP-1s before treatment. She was careful not to overclaim, repeatedly saying she's not a doctor and can't make definitive promises. That epistemic humility is worth acknowledging upfront.

Her core argument rests on two observations: IVF clinics are using GLP-1s as a pre-treatment protocol, and women with PCOS who start GLP-1 medications are "oftentimes ending up pregnant." She also flagged a genuine safety point, warning her audience to "be careful" because unintended pregnancies appear to be happening. The framing is anecdotal, drawn from DMs rather than clinical data, but the underlying science is more supportive than you might expect from a TikTok video.

Does the science back this up?

Partially, yes. The connection between GLP-1 receptor agonists, weight reduction, insulin sensitivity, and improved reproductive outcomes in women with PCOS has real mechanistic support. But "might help" is doing a lot of heavy lifting here.

PCOS is the most common cause of anovulatory infertility, and insulin resistance sits at the center of that dysfunction for many patients. GLP-1 agonists reduce insulin resistance and promote weight loss, both of which can restore ovulation. A 2023 meta-analysis by Moosa et al. in Frontiers in Endocrinology found that semaglutide and liraglutide improved menstrual regularity and ovulation rates in women with PCOS compared to placebo. Separately, reproductive endocrinologists have begun incorporating GLP-1 therapy into IVF prep protocols for patients with obesity, based on evidence that elevated BMI worsens IVF outcomes. A 2022 study by Mocanu et al. in Human Reproduction found that pre-IVF weight loss significantly improved live birth rates. Whether GLP-1s specifically drive that improvement, or weight loss does, is still being untangled.

What did they get wrong (or right)?

She got the directional signal right. GLP-1s appear to improve fertility-related markers, particularly for women with PCOS and obesity. The IVF pre-treatment anecdote is also grounded in real clinical practice, even if 15 to 20 DMs is not a study.

Where things get murkier is causality. She implies GLP-1 medications themselves are improving fertility, but the mechanism is indirect. It is weight loss and improved insulin sensitivity that restore ovulation, not some direct GLP-1 effect on the reproductive system, though GLP-1 receptors do exist in ovarian tissue and early research is exploring direct effects. She also skips a genuinely important safety issue: all major GLP-1 medications carry warnings against use during pregnancy. Semaglutide and tirzepatide are classified as FDA Pregnancy Category risk due to animal studies showing fetal harm. Women who become pregnant while on a GLP-1 should stop immediately and consult their physician. Her "be careful" warning was correct in spirit but far too vague for the stakes involved.

What should you actually know?

If you have PCOS and are considering a GLP-1 medication, the fertility conversation with your doctor needs to happen before you start, not after you get a positive test.

Here is what the evidence currently supports. GLP-1 agonists can improve ovulation rates in women with PCOS by reducing insulin resistance and body weight. This is real and clinically relevant. Some reproductive endocrinologists do use GLP-1 therapy as part of pre-IVF preparation for patients with obesity, and there is emerging rationale for this. However, GLP-1 medications are not approved as fertility treatments. They are not a replacement for evidence-based infertility care. Semaglutide and tirzepatide carry pregnancy warnings and should be discontinued before attempting conception. If you are sexually active and starting a GLP-1, use contraception unless you are actively trying to conceive under physician supervision. The warning in the video to "be careful" about unintended pregnancies is the most practically important thing she said, and it deserved more than a passing mention.